Sofosbuvir Ledipasvir

Approx. Rs 12,000 / Bottle(s)Get Latest Price

A flourishing enterprise in this domain, engaged in presenting a wide range of Hepcinat LP. This drug is used for treating patients suffering from chronic hepatitis C. The offered drug is highly effective and cures the issues within a limited time period. In addition with it, the formulation of the drug has been clinically approved for the related patients. Health chemical formulas and salts are used for forming the health drug. Also, clients can get the drug from us at reasonable rates from us.

Features:

Quick heal to infection

Stay for a longer time

Highly effective

Approx. Rs 700 / tabletGet Latest Price

Ledviclear offered is made available under brand name Ledviclear Tablets and contains Sofosbuvir 400 Mg & Ledipasvir 90 mg.

Features:

• Manufactured by Abbott
• Medication made available in tablet form in packaging of 28 tablets

Specifications:

• Contains Ledipasvir and Sofosbuvir
• Finding use in treatment of chronic hepatitis C virus infection genotype 1
• Ledipasvir and Sofosbuvir comprises combination of anti-viral medication
• Provides for effective treatment with high cure rate
• Helps prevent Chronic Hepatitis C Virus infection from multiplying in body
• Works by weakening virus and inhibiting its reproduction and replication

• Brand/Trade-Ledviclear Tablets
• Content -Sofosbuvir 400 Mg & Ledipasvir 90 mg
• Manufactured by-Abbott
• Form -Tablets
• Packing-28 Tablets
• Ledipasvir and Sofosbuvir

Approx. Rs 100 / PackGet Latest Price

Interferon beta-1b is a man-made version of a naturally occurring protein. It is used to treat patients with relapsing forms of MS (course of disease where symptoms flare up for a short time, then go away). Interferon beta-1b does not cure MS but may reduce the number of disease flare-ups. Interferon beta-1b may be prescribed for other uses.

Approx. Rs 1,300 / UnitGet Latest Price

Triomune is a co-formulation of three drugs commonly used in the management of HIV infection. It contains generic versions of the nucleoside reverse transcriptase inhibitors lamivudine (3TC) and d4T (stavudine) and the non-nucleoside RTI, nevirapine (NVP).